Guan Wang
- Cancer Research top 2%
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 17
- Histone Deacetylase Inhibitors Research 13
- Epigenetics and DNA Methylation 12
- Melanoma and MAPK Pathways 11
- Ubiquitin and proteasome pathways 11
- Oncology top 5%
- Toxicology top 2%
- Obstetrics and Gynecology top 5%
-
- Autophagy in Disease and Therapy 17
-
- Lung Cancer Treatments and Mutations 10
-
- Advanced Battery Materials and Technologies 9
- Journals
- Journal of Medicinal Chemistry (22 papers)European Journal of Medicinal Chemistry (16 papers)Acta Pharmaceutica Sinica B (7 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Guan Wang
213 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Cancer Research 749
- Molecular Biology 3.2k
- Oncology 924
- Toxicology 83
- Obstetrics and Gynecology 181
Countries citing papers authored by Guan Wang
This map shows the geographic impact of Guan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Wang more than expected).
Fields of papers citing papers by Guan Wang
This network shows the impact of papers produced by Guan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Wang. The network helps show where Guan Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 13 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 32 | |
| 13 | 2023 | 27 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 0 | |
| 18 | 2023 | 6 | |
| 19 | 2017 | 12 | |
| 20 | Lentivirus-mediated RNA Interference and Over-expression of CDK2AP1 CDNA Regulate CDK2AP1 Expression in Human Lung Cancer A549 Cells | 2011 | 1 |
About Guan Wang
Guan Wang is a scholar working on Physiology, Molecular Biology and Oncology, having authored 216 papers that have together received 5.9k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (17 papers), Protein Degradation and Inhibitors (17 papers), Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers), Melanoma and MAPK Pathways (11 papers), Ubiquitin and proteasome pathways (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Advanced Battery Materials and Technologies (9 papers). The work is most often cited by research in Cancer Research (749 citations), Molecular Biology (3.2k citations) and Oncology (924 citations). Guan Wang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Liang Ouyang, Richard Kendall, Kenneth A. Thomas, Bo Liu, Lu Feng, Lan Zhang, Junping Pei, Jifa Zhang, Haiyan Zhang and Yu Sun. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Bioorganic Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.